4.7 Article

TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis

Journal

CELL DISCOVERY
Volume 3, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/celldisc.2017.23

Keywords

TAK1; inflammation; fibrosis; pneumoconiosis

Categories

Funding

  1. Pneumoconiosis Compensation Fund Board of Hong Kong [MK/AL/extgrant/PCFB//0325/11sh]
  2. Hong Kong Research Grant Council Early Career Scheme [489213]
  3. Direct Grant for Research from the Chinese University of Hong Kong [4054138]

Ask authors/readers for more resources

Pneumoconiosis, caused by inhalation of mineral dusts, is a major occupational disease worldwide. Currently, there are no effective drugs owing to a lack of potential therapeutic targets during either the inflammation or fibrosis molecular events in pneumoconiosis. Here, we performed microarrays to identify aberrantly expressed genes in the above molecular events in vitro and found a hub gene transforming growth factor-beta-activated kinase 1 (TAK1), which was highly expressed and activated in pneumoconiosis patients as well as silica-exposed rats with experimental pneumoconiosis. Genetic modulation of TAK1 by CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9, RNA interference and overexpression indicated the important role of TAK1 in both inflammation and fibrosis in experimental pneumoconiosis. To achieve pharmacological TAK1 inhibition, we virtually screened out a natural product resveratrol, which targeted TAK1 at both N161 and A107 residues, and significantly inhibited TAK1 activation to attenuate inflammation and fibrosis in vitro. Consistently, in vivo prevention and intervention studies showed that resveratrol could inhibit pulmonary inflammation and fibrosis in silica-exposed rats.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Poly (ADP-ribose) polymerase 1 (PARP1) inhibition promotes pulmonary metastasis of osteosarcoma by ezrin phosphorylation

Fangfei Li, Xiaoqiu Wu, Xuekun Fu, Jin Liu, Wangze Song, Gary Guishan Xiao, Aiping Lu, Ge Zhang

Summary: This study revealed that PARP inhibitors have inhibitory effect on orthotopic osteosarcoma tumors, but they exacerbate pulmonary metastasis. Ezrin protein, which plays a crucial role in tumor metastasis, was found to interact with PARP1. Additionally, phosphorylation of ezrin was significantly increased during PARP inhibition, and it was found to have nuclear speckle localization and a function in mRNA export. Knockdown or inhibition of ezrin phosphorylation could partially reverse PARPi-induced metastasis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Article Endocrinology & Metabolism

Dynamic Alteration of the Gut Microbiota Associated with Obesity and Intestinal Inflammation in Ovariectomy C57BL/6 Mice

Hui Zhao, Qi Wang, Liqiu Hu, Shaojun Xing, Hui Gong, Zhe Liu, Panpan Qin, Jie Xu, Jihui Du, Wen Ai, Songlin Peng, Yifan Li

Summary: This study investigates the immediate and dynamic effects of estrogen deficiency on the gut microbiota and its potential impact on estrogen deficiency-related diseases. The results show that estrogen deficiency leads to alterations in the gut microbiota, which may be related to obesity and inflammation, potentially resulting in immune and metabolic disorders.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2022)

Article Geriatrics & Gerontology

m6A demethylase ALKBH5 drives denervation-induced muscle atrophy by targeting HDAC4 to activate FoxO3 signalling

Yuantong Liu, Tianjian Zhou, Qinghe Wang, Runhan Fu, Zengfu Zhang, Nandi Chen, Zhizhong Li, Guoyong Gao, Songlin Peng, Dazhi Yang

Summary: This study elucidates the roles and mechanisms of ALKBH5-mediated m(6)A demethylation in the control of muscle mass during denervation and the activation of FoxO3 signaling by targeting HDAC4. These results suggest that ALKBH5 is a potential therapeutic target for neurogenic muscle atrophy.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Chemistry, Physical

Sympathetic Neurostress Drives Osteoblastic Exosomal MiR-21 Transfer to Disrupt Bone Homeostasis and Promote Osteopenia

Cheng-Hu Hu, Bing-Dong Sui, Jin Liu, Lei Dang, Ji Chen, Chen-Xi Zheng, Songtao Shi, Na Zhao, Min-Yan Dang, Xiao-Ning He, Li-Qiang Zhang, Ping-Ping Gao, Nan Chen, Hui-Juan Kuang, Kai Chen, Xiao-Lin Xu, Xiao-Rui Yu, Ge Zhang, Yan Jin

Summary: Sympathetic neurostimulation through beta(1/2)-adrenergic receptor signaling triggers the transcription of miR-21 in osteoblasts, which is then transferred to osteoclast progenitors via exosomes to dictate osteoclastogenesis. Pharmacological inhibition of exosome release can suppress this miR-21 transfer and ameliorate bone loss under stress-induced depression conditions.

SMALL METHODS (2022)

Review Pharmacology & Pharmacy

Drug Discovery of DKK1 Inhibitors

Hewen Jiang, Zongkang Zhang, Yuanyuan Yu, Hang Yin Chu, Sifan Yu, Shanshan Yao, Ge Zhang, Bao-Ting Zhang

Summary: This article reviews the currently available or under study DKK1 inhibitors and discusses future research prospects.

FRONTIERS IN PHARMACOLOGY (2022)

Article Surgery

Efficacy of the Dynesys Hybrid Surgery for Patients with Multi-Segmental Lumbar Spinal Stenosis

Xiao Xiao, Gaoyang Chen, Song Wang, Junliang Liu, Erhu Lin, Ke Chen, Yucheng Xiang, Ke Zhan, Congcong Liu, Zhengbin Yuan, Minjie Yang, Shuyuan Zhong, Wanxin Zhen, Dazhi Yang, Songlin Peng

Summary: The efficacy of hybrid surgery and traditional surgery was compared in patients with multi-segmental lumbar spinal stenosis. It was found that the hybrid surgery preserved more motion range and had no early complications in a one-year follow-up.

FRONTIERS IN SURGERY (2022)

Article Dentistry, Oral Surgery & Medicine

Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress

Bingdong Sui, Jin Liu, Chenxi Zheng, Lei Dang, Ji Chen, Yuan Cao, Kaichao Zhang, Lu Liu, Minyan Dang, Liqiang Zhang, Nan Chen, Tao He, Kun Xuan, Fang Jin, Ge Zhang, Yan Jin, Chenghu Hu

Summary: This study reveals the crucial role of sympathetic cues in regulating bone homeostasis and neurostress-induced bone loss. The research focuses on the impact of sympatho-adrenergic activation on osteoclastogenesis and identifies miR-21 as a key regulator in this process. Targeted inhibition of miR-21 or suppression of osteoclastogenesis using drugs can protect bone against stress-induced osteopenias.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2022)

Article Multidisciplinary Sciences

Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation

Yuanyuan Yu, Luyao Wang, Shuaijian Ni, Dijie Li, Jin Liu, Hang Yin Chu, Ning Zhang, Meiheng Sun, Nanxi Li, Qing Ren, Zhenjian Zhuo, Chuanxin Zhong, Duoli Xie, Yongshu Li, Zong-Kang Zhang, Huarui Zhang, Mei Li, Zhenlin Zhang, Lin Chen, Xiaohua Pan, Weibo Xia, Shu Zhang, Aiping Lu, Bao-Ting Zhang, Ge Zhang

Summary: This study demonstrates that sclerostin has different mechanisms in protecting the cardiovascular system and inhibiting bone formation. By targeting sclerostin loop3, a drug can promote bone formation without affecting the cardiovascular system.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases

Lihui Chen, Gao Gao, Li Shen, Hua Yue, Ge Zhang, Zhenlin Zhang

Summary: Sclerostin, a secreted inhibitor of Wnt/beta-catenin signaling, is mainly produced by osteocytes and plays an important role in bone remodeling. This study investigated the association between serum sclerostin levels and bone turnover marker in patients with osteogenesis imperfecta (OI), X-linked hypophosphatemia (XLH), and Paget's disease of bone (PDB). The results suggest that sclerostin may serve as a biomarker for OI, XLH, and PDB.

DISEASE MARKERS (2022)

Article Oncology

Taraxasterol Inhibits Tumor Growth by Inducing Apoptosis and Modulating the Tumor Microenvironment in Non-Small Cell Lung Cancer

Junjie Lu, Bo Shuai, Zhexing Shou, Weina Guo, Cong Zhou, Xiaohu Ouyang, Haifeng Zhou, Junyi Li, Jing Cui, Feng Jiang, Kim Yun Jin, Alexey Sarapultsev, Fangfei Li, Ge Zhang, Shanshan Luo, Desheng Hu

Summary: Taraxasterol (TAX) has been found to inhibit the growth and migration of lung cancer cells, induce cancer cell apoptosis, and modulate the tumor microenvironment. These findings suggest that TAX could be a potential natural drug for lung cancer therapy.

CANCERS (2022)

Article Cell Biology

Methyltransferase Setdb1 Promotes Osteoblast Proliferation by Epigenetically Silencing Macrod2 with the Assistance of Atf7ip

Lijun Zhang, Liqun Xu, Xiaoyan Zhang, Ke Wang, Yingjun Tan, Gaozhi Li, Yixuan Wang, Tong Xue, Quan Sun, Xinsheng Cao, Ge Zhang, Zebing Hu, Shu Zhang, Fei Shi

Summary: This study reveals for the first time the role of the Atf7ip/Setdb1/Macrod2 axis in osteoblast proliferation under mechanical unloading, providing a potential protective strategy against unloading-induced bone loss.

CELLS (2022)

Article Veterinary Sciences

Development of a Real-Time TaqMan RT-PCR Assay for the Detection of NADC34-like Porcine Reproductive and Respiratory Syndrome Virus

Teng Tu, Maonan Pang, Dike Jiang, You Zhou, Xulong Wu, Xueping Yao, Yan Luo, Zexiao Yang, Meishen Ren, Aiping Lu, Ge Zhang, Yuanyuan Yu, Yin Wang

Summary: It is important for scientists to be able to communicate their work in a simple and concise manner, especially in an open-access online journal. The simple summary should contain a clear statement of the problem addressed, the aims and objectives, pertinent results, conclusions from the study, and their societal value. It should be written for a general audience, without technical terms or abbreviations. Submissions without a simple summary will be rejected.

VETERINARY SCIENCES (2023)

Review Biochemistry & Molecular Biology

Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges

Anna Hau-Yee Kong, Aston Jiaxi Wu, Olivia Ka-Yi Ho, Maggie Ming-Ki Leung, Alexis Shiying Huang, Yuanyuan Yu, Ge Zhang, Aiping Lyu, Min Li, King-Ho Cheung

Summary: Neuroinflammation is a precursor to neurodegenerative diseases, and targeting it with aptamers offers potential diagnostic and therapeutic applications. This review summarizes the use of aptamers for diagnosing and treating inflammatory biomolecules and cells associated with neurodegenerative diseases. It also discusses the potential of short nucleotides for targeted brain delivery and the challenges of using aptamers as therapeutic agents. Overall, this review assesses the potential of aptamers as a pioneering approach for CNS target delivery and the treatment of neuroinflammation and neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice

Luyao Wang, Yuanyuan Yu, Shuaijian Ni, Dijie Li, Jin Liu, Duoli Xie, Hang Yin Chu, Qing Ren, Chuanxin Zhong, Ning Zhang, Nanxi Li, Meiheng Sun, Zong-Kang Zhang, Zhenjian Zhuo, Huarui Zhang, Shu Zhang, Mei Li, Weibo Xia, Zhenlin Zhang, Lin Chen, Peng Shang, Xiaohua Pan, Aiping Lu, Bao-Ting Zhang, Ge Zhang

Summary: The sclerostin loop3-specific aptamer Apc001PE has been shown to promote bone formation without increasing cardiovascular risk in osteogenesis imperfecta (OI) mice, as granted orphan drug designation by US-FDA in 2019.

THERANOSTICS (2022)

Article Cell & Tissue Engineering

Circular RNA circStag1 promotes bone regeneration by interacting with HuR

Gaoyang Chen, Canling Long, Shang Wang, Zhenmin Wang, Xin Chen, Wanze Tang, Xiaoqin He, Zhiteng Bao, Baoyu Tan, Jin Zhao, Yongheng Xie, Zhizhong Li, Dazhi Yang, Guozhi Xiao, Songlin Peng

Summary: This study reveals that circStag1 plays a pivotal role in promoting bone tissue regeneration via the HuR/Wnt signaling pathway, which may provide new strategies to prevent bone metabolic disorders such as postmenopausal osteoporosis.

BONE RESEARCH (2022)

No Data Available